Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.72 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.72 |
| ▸ | LMNA | P02545 | 1/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8898751 | 1.00 | CYP1A2 (0.72) | CYP1A2MAPK1LMNAALDH1A1MEN1 | |
| SCHEMBL14533823 | 0.86 | CYP1A2 (0.54) | CYP1A2MAPK1LMNAALDH1A1MEN1 | |
| Austricin SCHEMBL4735162 | 0.85 | CYP1A2 (0.97) | CYP1A2MAPK1LMNAALDH1A1MEN1 | |
| Austricin SCHEMBL14190527 | 0.85 | CYP1A2 (0.97) | CYP1A2MAPK1LMNAALDH1A1MEN1 | |
| Austricin SCHEMBL14029373 | 0.85 | CYP1A2 (0.97) | CYP1A2MAPK1LMNAALDH1A1MEN1 | |
| SCHEMBL14215976 | 0.77 | CYP1A2 (0.71) | CYP1A2MAPK1LMNAALDH1A1MEN1 | |
| Lactucin SCHEMBL14215975 | 0.75 | CYP19A1 (0.43) | CYP1A2MAPK1LMNAALDH1A1 | |
| Lactucin SCHEMBL11891057 | 0.75 | CYP19A1 (0.43) | CYP1A2MAPK1LMNAALDH1A1 | |
| Lactucin SCHEMBL11030649 | 0.75 | CYP19A1 (0.43) | CYP1A2MAPK1LMNAALDH1A1 | |
| SCHEMBL14533824 | 0.68 | CYP1A2 (0.52) | CYP1A2MAPK1LMNAALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080124772-A1 | Plant enzymes for bioconversion | PLANT RESEARCH INTERNATIONAL B.V. | 2008-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080124772-A1 | Plant enzymes for bioconversion | STS, SQLE, CYP51A1 | CYP1A2 19/4885MAPK1 3955/4885LMNA 2821/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.